Skip to main content
Timothy Triche, MD, Pathology, Los Angeles, CA

Timothy Junius Triche MD

Anatomic Pathology, Clinical Pathology, Pediatric Pathology


Professor of Pathology, USC School of Medicine

Join to View Full Profile
  • 4650 W Sunset BlvdLos Angeles, CA 90027

  • Phone+1 323-361-3550

  • Fax+1 323-361-8052

Dr. Triche is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Timothy Triche is a pathologist in Los Angeles, CA and is affiliated with Children's Hospital Los Angeles. He received his medical degree from Tulane University School of Medicine and has been in practice 46 years. He specializes in anatomic pathology, clinical pathology, and pediatric pathology.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 1974 - 1975
  • Barnes-Jewish Hosp Wash U
    Barnes-Jewish Hosp Wash USurgical Pathology, 1973 - 1974
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1971 - 1973
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1971

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - 2025
  • MD State Medical License
    MD State Medical License 1988 - 2017
  • LA State Medical License
    LA State Medical License 1971 - 1978
  • Anatomic Pathology
    American Board of Pathology Anatomic Pathology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • Top Doctors:LA Area Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • A More Targeted Approach in Pediatric Cancer Therapy?
    A More Targeted Approach in Pediatric Cancer Therapy?August 18th, 2021
  • NanoValent Appoints Timothy Enns as Chief Executive Officer
    NanoValent Appoints Timothy Enns as Chief Executive OfficerJanuary 10th, 2017
  • Children’s Hospital Los Angeles Announces Development of Unique Next Generation Sequencing-Based Panel Designed for Pediatric Cancer Research
    Children’s Hospital Los Angeles Announces Development of Unique Next Generation Sequencing-Based Panel Designed for Pediatric Cancer ResearchFebruary 18th, 2016
  • Join now to see all

Grant Support

  • Dissecting the role of germline genetic variation and viral exposures as determinants of hematological disease predispositionVAN ANDEL RESEARCH INSTITUTE2024–2026
  • Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)NANOVALENT PHARMACEUTICALS, INC.2023–2026
  • The roles of genetics, hormones, and gender in sexually dimorphic immune responseVAN ANDEL RESEARCH INSTITUTE2022–2026
  • Integrated radiomic and liquid biopsy monitoring in SWOG S1802: A phase 3 therapeutic trial for metastatic prostate cancerUNIVERSITY OF SOUTHERN CALIFORNIA2021–2026
  • Integrated radiomic and liquid biopsy monitoring in SWOG S1802: A phase 3 therapeutic trial for metastatic prostate cancerUNIVERSITY OF SOUTHERN CALIFORNIA2021–2026
  • Translation Of Predictive Cancer Biomarkers Into Clinical PracticeNational Cancer Institute2009–2010
  • Microarray Core FacilityNational Cancer Institute2006–2010
  • Diagnostic And Prognostic Sarcoma SignaturesNational Cancer Institute2005–2009
  • Gene Expression In Sarcomas Of Childhood And AdolescenceNational Cancer Institute2000–2004
  • Core--MicroarrayNational Cancer Institute2001–2002

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: